tirzepatide and blood pressure New Study Finds Use Lowered in Patients with Obesity New Study Finds Tirzepatide Use

Weight loss was the deciding factor: 78% of satisfied users reported losing weight, compared to only 33% of dissatisfied users, even though both groups experienced similar rates of stomach problems

As adoption advances, doctors could turn to retatrutide not just for weight loss but for addressing the multiple co-morbidities of obesity

The SURMOUNT-4 trial found that patients who continued tirzepatide 15 mg lost an additional 5.5% of body weight over 52 weeks, while those switched to placebo regained approximately 14.0% (Aronne et al., JAMA 2024)

While the release of mercury from dental amalgams is undeniably present, your body may be detoxifying it without a problem